7. Watson Pharmaceuticals ( WPI) is an integrated global pharmaceutical company dealing in generic and brand pharmaceutical products. The company manages its business into three operating segments: Generics, Brands and Distribution. Watson will announce third-quarter results Nov. 1.

Net income for the third quarter of 2011 is estimated at $132.54 million on sales of $1.09 billion, higher than net income of $105.80 million recorded on $882.4 million sales for the same period in 2010, as per analysts polled by Bloomberg. For the quarter, earnings per share are forecast at $1.05 cents, vs. 85 cents registered in 2010 third quarter. Meanwhile, a multifold increase in operating profit is likely at $223.45 million, rising from $34.50 million in the year-ago period.

Of the 22 analysts covering the stock, 59% recommend a buy and the rest rate a hold. There are no sell ratings on the stock. Analysts polled by Bloomberg expect the stock to gain an average 12.1% to $78.00 from current levels over the next 12 months.

If you liked this article you might like

Apple Watch Issues Pull Nasdaq to Session Lows, Dow and S&P 500 in Flux

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux

The 6 Medications Being Used to Tackle the Opioid Epidemic

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Friday Selloff May Be On Its Way; Tenet Gears Up for Sale -- ICYMI